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Since  the  turn  of the  century,  numerous  case  reports  have  appeared  showing  a 
temporal relationship between the onset of certain viral infections and the subsequent 
development of diabetes (1). In the late 1960s, Gamble and co-workers reported that 
newly diagnosed juvenile-onset diabetics had  higher neutralizing antibody titers to 
Coxsaekie virus B4 than a  comparable group of nondiabetie patients (2-4).  Reports 
from  other  laboratories,  however,  failed  to  confirm  these  observations  and  solid 
evidence that viruses produce diabetes in humans is still lacking (5-8). 
In contrast to the data from humans, there is good evidence that at least one virus, the M- 
variant of encephalomyocarditis (EMC) ~ virus, can infect and destroy pancreatic beta cells in 
certain inbred strains of mice and produce an insulin-dependent hyperglycemia (1). Coxsackie 
viruses also have been implicated as a possible cause of diabetes in mice, but the data is more 
controversial (1). Since the early 1950s, it has been known that members of the Coxsackie virus 
B  group  can  infect and  destroy pancreatic acinar cells while  leaving the adjacent  islets of 
Langerhans intact (9-13). However, in  1971 Burch and associates (14) reported that infection 
of suckling mice with Coxsackie virus B4 resulted in degranulation of a  variable number of 
beta cells and, by electron microscopy, they observed some alterations in the architecture of the 
islets. Similar types of observations were made with Coxsackie viruses B 1 and B3 (15,  16), but 
in none of these cases was the degree of beta cell damage quantitated nor were blood glucose 
levels reported. Coleman and colleagues (17) then reported that infection of CD-1 mice with 
Coxsackie virus B4 resulted in a transient elevation of glucose, (i.e.,  15-20 days after infection), 
in the absence of an absolute decrease in the concentration of insulin in the blood. Subsequently, 
Coleman et al., were unable to reproduce their initial observations (personal communication), 
and extensive studies by Ross et al. and Ross and Notkins also failed to demonstrate elevated 
blood glucose levels, abnormal glucose tolerance tests, beta cell damage, or viral antigens in 
islets of mice inoculated with various members of the Coxsackie virus B group  (11,  12). The 
most plausible explanation for these conflicting reports would appear to be that, in mice, most 
strains of Coxsackie virus are minimally beta-tropic, and that if beta ceils are damaged, the 
number is usually insufficient to produce substantial alterations in glucose metabolism. 
Recently, it was shown that beta cells grown in culture would support the replication of 
certain viruses (18-21) and that the tropism of these viruses for beta cells could be increased by 
serial passage in beta cell cultures (21, 22). The present experiments were initiated to evaluate 
both the effect of passage in beta cell cultures and the influence of the host on the diabetogenic 
capacity of Coxsackie virus B4. 
Materials and  Methods 
Pancreatic Beta  Cell Cultures.  Pancreas were obtained from suckling SJL/J  mice, and beta 
cell monolayers were prepared essentially as described (18).  Staining of the monolayer with 
1  Abbreviations used in  this paper: EMC,  encephalomyoearditis;  FITC, fluorescein isothiocyanate;  IRI, 
immunoreaetive insulin; pfu, plaque-forming units; SME, secondary mouse embryo. 
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fluorescein isothiocyanate-labeled antibody to insulin indicated that 40-70% of the cells were 
beta cells (18). 
Monolayers of SJL/J secondary mouse embryo (SME) fibroblasts were prepared by standard 
methods. 
Virus.  Coxsackie virus  B4  (JVB)  was  originally obtained  from  the  Research  Resources 
Branch of the National Institute of Allergy and Infectious Diseases. Stock pools of Coxsackie 
virus B4 were prepared either in SME cell cultures (unpassaged virus) or by serial passage in 
beta cell cultures (passaged virus), using a multiplicity of infection of 10. Virus was harvested 
48-72  h  after inoculation. The source and preparation of the M-variant of EMC  virus are 
described elsewhere  (18,  23).  The  titer of these  viruses, expressed as  plaque-forming units 
(pfu/ml), was determined on SME monolayers. 
Preparation of Antiserums.  Antiserums to Coxsackie virus B4 and EMC virus were prepared 
in rabbits and mice, respectively. Neutralization titers are expressed as the reciprocal of the 
highest dilution of serum that inhibited plaque formation by 50%. Antiserum prepared against 
unpassaged Coxsackie virus B4 gave the same 50% neutralization titer (i.e., 500)  when tested 
against either unpassaged virus or virus that had been passaged 14 times in beta cell cultures. 
Fluorescein isothiocyanate (FITC)-labeled antiserums to virus and insulin were obtained and 
prepared as described previously (18). 
Mice.  Unless otherwise indicated, 5- to 6-wk old SJL/J  male mice, obtained  from The 
Jackson Laboratory, Bar Harbor, Maine, were used in all experiments and the animals were 
inoculated intraperitoneally with  l0  b.° pfu of Coxsackie virus B4 which had been passaged 14 
times in beta cell cultures. 
Glucose and Insulin Assays.  Blood glucose levels and glucose tolerance tests were performed as 
described previously (24). Nonfasting glucose levels were measured 7 and 14 days after infection 
and the 60-rain glucose tolerance tests were performed 10 and 17 days after infection. The data 
obtained on these 4 days were used to calculate the glucose index (24)  for each mouse. The 
mean glucose index of 80 uninfected mice was  162  zt:  16 mg/dl. Any mouse with a  glucose 
index greater than 210 mg/dl, which was 3 SD above the mean, was scored as diabetic. 
In some experiments, only nonfasting glucose levels were determined. The mean nonfasting 
glucose of 100 uninfected animals was 151:1:22 mg/dl. In these experiments, any mouse with 
a nonfasting glucose greater than 217 mg/dl (3 SD above the mean) was scored as diabetic. 
The concentration of insulin in the pancreas and plasma of infected and uninfected mice 
was measured by radioimmunoassay (25) using mouse insulin as the standard. 
Results 
Passage of Coxsackie Virus B4 in Pancreatic Beta Cell Cultures.  Coxsackie virus B4 that 
had been grown in SME cells was serially passaged in beta cell cultures. Virus from 
selected passages was titrated and  105.0 pfu were inoculated into mice. The data in 
Fig.  1.  show  that  unpassaged  virus  failed  to  raise the  glucose index  above control 
values.  Beginning,  however,  with  the  third  passage,  a  number  of animals  showed 
elevated glucose indexes.  By  the  fifth passage, over 35%  of the  inoculated  animals 
became  diabetic and  by the  14th  passage,  close to  80%  of the  inoculated  animals 
became diabetic. In all subsequent experiments, virus from the 14th passage was used. 
Virus-Induced Metabolic Alterations.  To see whether the severity of the diabetes was 
dependent  upon  the dose of the virus, animals were inoculated with  105-107  pfu of 
passaged or unpassaged  virus.  Approximately 40%  of the mice inoculated with  104 
pfu  of passaged  virus  developed  diabetes.  This  increased  to  80%  when  mice  were 
inoculated with  105  pfu  of passaged  virus.  No  further  increase was  observed when 
animals were inoculated with 106 or 10  v pfu ofpassaged virus. In contrast, unpassaged 
virus did not produce diabetes even when mice were inoculated with  107 pfu of virus. 
The duration of the hyperglycemia induced by Coxsackie virus B4 is illustrated in 
Fig. 2. At  13 days after inoculation, the mean nonfasting glucose was 292 mg/dl and 
86%  of the animals were hyperglycemic. The severity of the hyperglycemia and the 1070  VIRUS-INDUCED DIABETES MELLITUS 
Fro.  1.  Effect  of passage of Coxsackie virus B4 in beta cell cultures on the diabetogenic capacity 
of the virus. Virus harvested after each passage was titered in  SME cells and  105.0 pfu were 
inoculated intraperitoneally into mice. Shaded horizontal area represents the mean glucose index of 
80 uninfected mice ±  3 SD. Each point represents the glucose index of an infected animal. 
percentage of hyperglycemic animals,  however,  declined  rapidly.  At  30  days  after 
inoculation, the mean nonfasting glucose was about 200 mg/dl and only 43% of the 
animals were hyperglycemic. At  80 days, only 2% of the  animals still had elevated 
glucose levels.  Mice  inoculated  with  unpassaged  virus had  glucose levels similar to 
uninfected mice. 
When the nonfasting glucose of individual animals was examined over a  period of 
80 days, three general patterns  were observed  (Fig.  3).  The most common pattern, 
found in up to 80% of the animals, was a  transient hyperglycemia lasting from 2- to 
8-wk. The second pattern, occurring in less than 5% of the animals, was a severe and 
persistent  hyperglycemia  lasting  for  at  least  12  wk.  The  third  pattern,  found  in 
15-30%  of the  animals,  was  characterized  by a  failure  to  develop  hyperglycemia. 
Despite  the  failure  of these  latter  animals  to  develop  hyperglycemia,  many  had 
distinctly abnormal glucose tolerance tests. Close to 45% of the mice that had normal 
nonfasting glucose levels 7 days after infection showed an abnormal response when 
administered a glucose load (data not shown). In contrast, only 1% of uninfected mice 
responded abnormally. Abnormal glucose tolerance tests were also found at 3 wk after 
infection in approximately 20% of the animals in which the nonfasting glucose levels 
had returned to normal. 
To study the relationship between virus-induced hyperglycemia and immunoreac- 
tive insulin  (IRI), mice were infected with Coxsackie virus B4 and, at different times 
thereafter,  the  concentration  of IRI  in  the  pancreas  was  determined  and  plotted 
against the concentration of nonfasting glucose in the blood (Fig. 4 A). The mean IRI 
in  the  pancreas  of uninfected  animals was  163  -  15  #g/gin.  Within  2  days  after 
infection, the concentration of IRI began to decline and at 4 days, 50% of the animals 
had less than 50 #g IRI per g/pancreas.  Depressed IRI was even more apparent on 
days 6,  7,  and  14.  A  number of animals had  less than  20  #g  IRI per  g/pancreas. 
When nonfasting glucose levels were plotted against insulin levels, some of the animals 
were found to be slightly hypoglycemic at 2 days after infection. Beginning at 4 days, 
however, a number of animals became hyperglycemic with glucose levels between 200 
and 500 mg/dl. On 6, 7, and  14 days after infection, the animals could be segregated JI-WON  YOON,  TAKASHI  ONODERA,  AND  ABNER  LOUIS  NOTKINS  107 1 
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Fzc.  2.  Duration of Coxsackie virus B4-induced hyperglycemia. Mice were inoculated with  10  5.0 
pfu of Coxsackie virus B4 and at  different times thereafter, nonfasting blood glucose levels were 
determined and  the percentage of animals with blood glucose levels 3  SD  above  the mean  of 
uninfected animals was calculated. (-0-) passaged Coxsackie virus B4 (60 mice); (-O-) unpassaged 
Coxsackie virus B4  (20  mice);  (11-)  uninfected (20  mice). Points represent the mean nonfasting 
glucose and vertical bars the standard error. 
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FIG.  3.  Representative glucose patterns of individual mice infected with Coxsackie virus B4. Mice 
5.0  were inoculated with  10"  pfu of Coxsackie virus B4 and at different times thereafter nonfasting 
glucose levels were determined. Each line represents a single mouse. 
into two groups: one with normal pancreatic IRI and normal glucose levels; the other 
with depressed pancreatic IRI and elevated glucose levels. 
The concentration of IRI in the plasma and its relationship to nonfasting glucose is 
plotted in Fig. 4B. The mean concentration of IRI in the plasma of uninfected mice 
was 4.3  :t:  0.23 ng/ml. Within 2 days after infection, a  number of animals showed 
signs of hyperinsulinemia (IRI between 5 and 6 ng/ml), probably secondary to the 
release of insulin from damaged beta cells. This was followed, beginning on day 4, by 
hypoinsulinemia and hyperglycemia. As in Fig. 4 A, the animals could be segregated 1072  VIRUS-INDUCED DIABETES MELLITUS 
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Fla.  4.  Relationship of concentration of nonfasting glucose (NFG) in the plasma to the concentra- 
tion  of IRI  in  (A)  pancreas  and  (B)  plasma  at  different  times after  infection  with  10  5 pfu  of 
Coxsackie virus B4. Each point represents an individual mouse. (O)  uninfected mice; (0)  infected 
mice. 
into two groups: one with normal plasma IRI and normal glucose levels and the other 
with depressed plasma IRI and elevated glucose levels. 
Destruction of Beta  Cells and Demonstration of Viral Antigens.  To determine whether 
the  alterations  in  insulin  might  be secondary  to Coxsackie virus-induced  beta cell 
damage,  sections  of pancreas  from  infected  and  uninfected  mice  were  examined 
microscopically. Islets from animals infected with Coxsackie virus B4 revealed infil- 
tration  of  mononuclear  cells  and  disruption  of  the  architecture  of  the  islets  of 
Langerhans (Figs. 5 A-C). Mild inflammatory changes were seen within 3-4 days after 
infection  and  the  inflammation was maximal at  about  5  days.  The severity of the 
inflammatory changes varied considerably among animals and within a  single pan- FIG.  5.  Pathologic changes in the islets of Langerhans after infection with Coxsackie virus B4. (A) 
Section of pancreas from uninfected mouse showing a normal islet surrounded by acinar cells (H 
and E  ×  550). (B) Section of pancreas 5 days after infection showing approximately one-third of 
the islet infiltrated with mononuclear cells (H and E  ×  550). (C) Section of pancreas 5 days after 
infection  showing extensive  infiltration of entire islet with mononuclear and occasional  polymor- 
phonuclear leukocytes (H and E  ×  550). 
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FXG. 6.  Coxsackie virus B4 antigens in islets of Langerhans. Frozen sections from pancreas taken 
4 days after infection and stained with FITC-labeled antibody to Coxsackie virus B4 (×  340).  (A) 
Section showing an islet with scattered cells containing viral antigens in the cytoplasma. (B) Section 
showing an islet with focal areas of infection. (C) Section of an islet with viral antigens in most of 
the cells. The surrounding acinar cells are relatively free of viral antigens in all three sections. JI-WON YOON,  TAKASHI ONODERA,  AND ABNER LOUIS NOTKINS 
TABL~ I 
Prevention of Virus-lnduced Diabetes by Specific Anti-Viral Serum* 
1075 
Antiserum 
Coxsackie-virus B4  EMC Virus 
Glucose:~ in-  Diabetic  Glucose:[:  index  Diabetic  dex 
Mean ± SD  %  Mean ± SD  % 
None  338 ±  116  88  264 ±  90  618 
Anti-Coxsackie virus B4§  148 ±  12  0  242 ±  89  58 
Anti-EMC Virus§  301  ±  116  60  168 ±  52  5 
*  Coxsackie-virus B4 (1.0 x  10  °'° pfu/ml) or EMC virus (1.0 ×  105.0  pfu/ml) was incubated with an equal 
volume of antiserum or control medium for 40 min at room temperature. Each mouse then received 0.3 
ml of the appropriate reaction mixture intraperitoneaUy and glucose indexes were determined. 
Each group contained approximately 15 mice. 
§ The 50% neutralization titer was adjusted to 512. 
creas with some islets showing little  if any change while others showed moderate to 
extensive infiltration of cells. Normal appearing islets often were seen adjacent to islets 
showing extensive infiltrates.  In some cases, only a  portion of the islet was involved. 
In the more severe cases, beta cell destruction, and coagulation necrosis were observed. 
At 2 wk after infection, atrophic islets were sometimes seen. 
To show  that  the  virus  was  actually  replicating  in  beta  cells,  sections  from  the 
pancreas of infected mice were stained with FITC-labeled antibody to Coxsackie virus 
B4  (Figs.  6A-C).  Within  3  days  after  infection,  viral  antigens  were  seen  in  the 
cytoplasma of beta cells and maximal involvement occurred at about 4 days. After 7 
days,  the  viral  antigens  were  faint  and  difficult  to  detect.  The  degree  of beta  cell 
involvement varied considerably with some islets showing only a  few cells and others 
showing almost all the cells containing viral antigens.  Occasional acinar and ductal 
cells also contained viral antigens. 
Evidence  that  the histologic and  metabolic changes were not due  to inadvertent 
contamination  of beta  cell-passaged  Coxsackie  virus  with  EMC  virus  comes  from 
immunofluorescence  and  neutralization  studies.  Islets  from  animals  infected  with 
Coxsackie  virus  B4  stained  strongly  positive  when  incubated  with  FITC-labeled 
antibody to Coxsackie virus B4, but not when incubated with FITC-labeled antibody 
to EMC virus  (data not shown). Conversely, islets from animals infected with EMC 
virus stained strongly positive when incubated with FITC-labeled antibody to EMC 
virus, but not when incubated with FITC-labeled antibody to Coxsackie virus B4. In 
addition,  as seen  in Table  I, animals  inoculated with  Coxsackie  virus B4 that  had 
been incubated with antibody to Coxsackie virus B4 did not develop diabetes, whereas 
animals inoculated with Coxsackie virus B4 that had been incubated with antibody 
to EMC  virus did develop diabetes.  Conversely, incubation  of EMC  virus with  the 
homologous,  but  not  the  heterologous,  antibody  prevented  the  development  of 
diabetes. 
Influence of the Host on the Development  of Diabetes.  To see whether the induction of 
diabetes  by Coxsackie virus B4 was influenced by the host, several  different  inbred 
strains  of mice were infected and glucose indexes determined.  The data  in Table II 
show  that  male  SWR/J,  SJL/J,  and  NIH  Swiss  mice  readily  developed  diabetes, 
whereas  C57BL/6J,  CBA/J,  AKR,  BALB/c,  C3H/J,  DBA/1J,  and  DBA/2J  mice 1076  VIRUS-INDUCED DIABETES MELLITUS 
TABLE II 
Induction of Diabetes by Coxsackie Virus B4 in Different Inbred Strains of 
Mice* 
Strain of mouse  Sex  Glucose index  Diabetic 
Mean  ±  SD  % 
SJL/J  M  253  ::t:  83  72 
SWR/J  M  270  zt:  91  75 
NIH Swiss  M  325  ±  119  80 
C57BL/6J  M  129  ±  27  0 
CBA/J  M  157  ±  15  0 
AKR  M  113  +  32  0 
BALB/C  M  92  ±  40  0 
C3H/J  M  87  +  33  0 
DBA/IJ  M  159  :t:  25  0 
DBA/2J  M  140  ±  25  0 
SJL/J  F  216  ±  87  33 
SWR/J  F  233  :t:  25  50 
NIH Swiss  F  174  +  33  10 
CBA/J  F  153  ±  17  0 
AKR  F  125  ±  14  0 
DBA/IJ  F  100  ~  30  0 
DBA/2J  F  158  +  10  0 
*  Mice, 5- to 6-wk old, were infected intraperitoneally with 5  X  10  s'° pfu of 
Coxsackie virus B4. Glucose indexes were determined and the percentage of 
diabetic animals calculated. Each group contained between 30 and 40 mice. 
failed to develop diabetes. A similar pattern was observed in females of these strains, 
except the severity of the hyperglycemia and the percentage of diabetic animals were 
lower. This was especially the case with NIH Swiss females. These studies suggest that 
the genetic background of the host influences the development of diabetes. 
Discussion 
The  present  experiments  show  that  Coxsackie  virus  B4  can  infect  and  destroy 
pancreatic beta ceils in certain inbred strains of mice. The destruction of beta ceils 
results  in  a  decrease  in  the  insulin  content  of the  pancreas.  This  in  turn  leads  to 
hypoinsulinema  and  the  subsequent  development of hyperglycemia. Thus,  the  de- 
struction of beta cells by the virus appears to be responsible for the insulin-dependent 
hyperglycemia.  Whether  Coxsackie  virus  B4  also  infects  and  damages  the  other 
hormone-producing cells in the islets of Langerhans, such as the glucagon-producing 
alpha cells or the somatostatin-producing  delta ceils has not  yet been  determined. 
Virus-induced alterations in the functional capacity of these cells might also contribute 
to the hyperglycemic state. 
As  in  the  case  of EMC  virus  (1),  the  degree  of beta  cell  damage  produced  by 
Coxsackie virus B4 varies considerably among animals, even though inbred strains of 
mice of the same age and sex are used. This variation in beta cell damage is, in all 
probability,  responsible  for  the  observed  differences  in  the  metabolic  response  of 
individual  animals  (Fig.  3).  In  the  majority of the  animals,  the  hyperglycemia is 
transient. This may very well be due to the fact that a sufficient number of beta cells 
are left intact  after the  infection  so that  proliferation  and/or  hypertrophy of these 
cells results in metabolic compensation. JI-WON YOON, TAKASHI ONODERA, AND ABNER LOUIS NOTKINS  1077 
The  similarities  of  the  diabetes-like  syndrome  produced  by  EMC  virus  and 
Coxsackie virus B4 were so striking that a number of steps were taken to rule out the 
possibility of inadvertent contamination of our beta cell-passaged Coxsackie virus B4 
pool with EMC virus. First, sections of pancreas from animals infected with Coxsackie 
virus B4 or EMC virus were found to stain strongly positive with the homologous, but 
not heterologous, FITC-labeled antiserums. Second, incubation of Coxsackie virus B4 
or EMC virus with the homologous, but not heterologous, antiserums before inocula- 
tion  of these  viruses  into  animals  prevented  the  development of diabetes.  Third, 
neutralization tests showed that  antiserum  prepared against  Coxsackie virus B4 or 
EMC virus were highly specific for the homologous virus, although a  low degree of 
cross-reactivity was observed (unpublished data). Fourth, a second isolate of Coxsackie 
virus B4, obtained from another laboratory, failed to produce diabetes when inocu- 
lated  into SJL/J  mice, but  upon. serial passage  in  beta cell cultures,  also  became 
diabetogenic (unpublished data). Taken together, these studies strongly argue against 
inadvertent  contamination  of the beta ceU-passaged Coxsackie virus B4  pool with 
EMC virus. 
Precisely how  passage  of Coxsackie virus  B4  in  cultures enriched for beta cells 
increases its diabetogenic capacity is  not  known, but  alterations  in  the  tropism of 
viruses  after  serial  passage  in  animals  or  tissue  culture  is  a  widely  recognized 
phenomenon.  In  the case of Coxsackie virus B4, there are at  least  several ways in 
which this could have occurred. First, the original stock virus pool may have contained 
two populations of virus; one tropic for beta cells and the other not tropic for beta 
cells. Growing the stock virus in cultures enriched for beta cells may have favored the 
replication of the beta-tropic virus.  Second, mutation or recombination may have 
taken place during serial passage of the virus in culture and the presence of beta cells 
may have favored the selection of the beta-tropic virus. Third, nongenetic adaptation 
(e.g., host-controlled alterations in viral antigens or coat) may have occurred, thereby 
increasing the capacity of the virus to bind to beta cells.  By plaque-purifying the 
virus and by passaging the virus in beta cell cultures from different inbred strains of 
mice, it might  be possible to distinguish  between a  stable mutant  and  nongenetic 
adaptation. These experiments are now underway. 
The present study also shows  that  the capacity of Coxsackie virus B4  to induce 
diabetes is influenced by the genetic background of the host. As in the case of EMC 
virus, only certain inbred strains of mice were found to develop diabetes when exposed 
to Coxsackie virus B4 and  male mice developed more severe diabetes than  female 
mice. Moreover, the strains of mice known to be susceptible to EMC-induced diabetes 
(18, 24, 26-28) were found to be the strains susceptible to Coxsackie virus B4-induced 
diabetes (Table II). Similarly, the strains of mice that did not develop diabetes when 
exposed to EMC virus, did not develop diabetes when exposed to Coxsackie virus B4. 
The  only  exception,  thus  far,  appears  to  be  DBA/1J  and  DBA/2J  mice  which 
developed diabetes when exposed to EMC  virus (26), but did not develop diabetes 
when  exposed to  Coxsackie virus  B4.  In  the case of EMC  virus, it  is  known  that 
susceptibility to diabetes is inherited as an autosomal recessive trait (24, 28), and that 
beta cells from strains of mice that  develop diabetes are more susceptible to EMC 
infection than beta cells from strains of mice that do not develop diabetes (18, 27, 29). 
Moreover, recent  data  suggest  that  a  single  locus may control susceptibility  (28). 
Based on these observations, it has been postulated (but not proven) that the gene 
product controlling susceptibility might be a receptor for the virus on the surface of 1078  VIRUS-INDUCED DIABETES MELLITUS 
beta ceils (29).  If this turns out to be the case, then it would not be unreasonable to 
suspect  that  host-determined  differences in  the induction  of diabetes  by Coxsackie 
virus B4 also might be related to viral receptors on the surface of beta cells. In fact, 
one explanation  for the similarity in  the responses of inbred  strains of mice to the 
diabetes-inducing  capacity  of Coxsackie  virus  B4  and  EMC  virus  might  be  the 
existence of a  common receptor on  the surface of beta ceils which  is used  by both 
viruses.  The  sharing  of a  common  receptor  by  apparently  unrelated  viruses  has 
recently been reported (30). 
The experiments described here with Coxsackie virus B4, together with the recent 
demonstrations  that  reovirus  type  3  also  can  infect  mouse  beta  ceils  and  cause 
metabolic alterations  (22),  show that  two viruses which  are widely disseminated in 
the human population  are capable of producing a  diabetes-like syndrome in  mice. 
What role, if any, these viruses actually play in the etiology of  juvenile-onset diabetes 
is still not known. 
Summary 
Coxsackie virus B4 that had been passaged in cultures enriched for pancreatic beta 
cells  produced  a  diabetes-like  syndrome  when  inoculated  into  SJL/J  mice.  The 
infection resulted in insulitis and destruction of beta cells. Viral antigens were found 
in beta cells by staining with fluorescein-labeled antibody to Coxsackie virus B4. The 
destruction of beta cells led to a decrease in the immunoreactive insulin content of the 
pancreas and hypoinsulinemia. The reduction in immunoreactive insulin correlated 
inversely with the elevation of glucose in the blood and over 80% of the animals were 
found to be hyperglycemic within  14 days after infection. The percentage of animals 
with hyperglycemia decreased with time and at the end of 60 days, less than 5% of 
the  animals were  still  hyperglycemic. However,  many of the  normoglycemic mice 
were found to be metabolically abnormal when evaluated by glucose tolerance tests. 
Studies  on the susceptibility of the host showed  that only certain  inbred  strains of 
mice became diabetic when infected with Coxsackie virus B4.  It is concluded  that 
both  the  passage  history  of  the  virus  and  the  strain  of  the  host  influence  the 
development of diabetes. 
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